|
equine assay data sheet
Hendra virus (HeV) NOTE: THIS TEST IS NOT PERFORMED
ON CLINICAL SAMPLES TAKEN FROM HORSES OWNED OR LOCATED IN THE STATE OF
CALIFORNIA.
Test
code: S0273 - Ultrasensitive qualitative detection of Hendra virus by reverse transcription coupled real time
polymerase chain reaction
Hendra virus (HeV) is a rare, zoonotic (animal-to-human) virus that
causes severe and often fatal disease in horses and humans. It
belongs to the genus Henipavirus in the family Paramyxoviridae,
the same family as the related Nipah virus. Hendra virus has a
non-segmented, negative-sense, single-stranded RNA genome
typical of the family. The genome size is about 18 kb.
The virus was first identified in 1994 during an outbreak in the Brisbane
suburb of Hendra, Australia. It is found only in Australia,
where it is maintained in nature by fruit bats (flying foxes) of
the genus Pteropus.
These bats are the natural reservoir and typically do not show
symptoms. Horses become infected through contact with bat urine,
saliva, droppings, or contaminated fruits and plants. Humans get
infected through close contact with sick horses, particularly
exposure to their respiratory secretions, blood, or other bodily
fluids during handling, veterinary care, or necropsy. There is
no documented human-to-human transmission, and horse-to-horse
transmission is limited.
When horses are infected with the virus, they can develop a sudden onset
of fever, depression, rapid breathing, nasal discharge,
neurological signs such as ataxia, tremors, and head tilt,
followed by rapid deterioration. Many cases are fatal. In
humans; the infection initially presents with flu-like symptoms
such as fever, headache, cough, sore throat, tiredness, and
myalgia. However, the symptoms can progress rapidly to severe
respiratory illness or neurological disease including
encephalitis or meningitis, with drowsiness, confusion,
seizures, or coma.
There is no specific approved antiviral treatment for humans, so
supportive care in an intensive care unit is often the main
approach. Vaccination of horses is the best method of preventing
the disease.
Diagnosis of the viral infection by viral culture is very slow and
requires high-containment facilities. Serological methods may
not be suitable for acute disease detection as it takes time for
antibodies to develop. PCR is often used to detect the virus due
to its high specificity and sensitivity (Feldman et al., 2009;
Smith et al., 2001).
Utilities:
-
Help ensure that horse populations are free of Hendra
virus
-
Early prevention of spread of this virus
-
Minimize personnel exposure to this virus
-
Safety monitoring of biological products that derive
from horses
References:
Feldman KS, Foord A, Heine HG, Smith IL, Boyd V,
Marsh GA, Wood JL, Cunningham AA, Wang LF. Design and evaluation
of consensus PCR assays for henipaviruses. J Virol Methods. 2009
Oct;161(1):52-7.
Smith IL, Halpin K,
Warrilow D, Smith GA. Development of a fluorogenic RT-PCR assay
(TaqMan) for the detection of Hendra virus. J Virol Methods.
2001 Oct;98(1):33-40.
Specimen requirements: 0.2 ml whole blood in EDTA (purple top) tube, or
nasal swab, or oropharyngeal swab, or rectal mucosal swab, or 0.2 ml
feces, or 0.2 ml urine, or urine soaked swab, or 0.2 ml cell
culture, or 0.2 ml fresh or frozen
tissue.
Contact Zoologix if advice is needed to determine an appropriate specimen type for a specific diagnostic application. For specimen types not listed here, please contact Zoologix to confirm specimen acceptability and shipping instructions.
For all
specimen types, if there will be a delay in shipping, or during
very warm weather, refrigerate specimens until shipped and ship
with a cold pack unless more stringent shipping requirements are
specified. Frozen specimens should be shipped so as to remain
frozen in transit. See shipping
instructions for more information.
Turnaround time:
2 business days
Methodology:
Qualitative
reverse transcription coupled real time PCR
Normal range:
Nondetected
|